BPC-157
Body Protection Compound-157, a synthetic pentadecapeptide derived from a portion of gastric juice protein. Most-studied peptide in the recovery category for tendon, ligament, gastrointestinal lining, and soft-tissue repair. Available compounded (typically injectable 250 mcg–500 mcg, twice daily).
Body Protection Compound-157, a synthetic pentadecapeptide derived from a portion of gastric juice protein. Most-studied peptide in the recovery category for tendon, ligament, gastrointestinal lining, and soft-tissue repair. Available compounded (typically injectable 250 mcg–500 mcg, twice daily). Mechanism: Promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptor expression in tendon fibroblasts, and modulates nitric oxide synthesis. Evidence: Strong preclinical (rodent) evidence for tendon/ligament/GI healing. Limited published human trial data; most clinical use is off-label by sports medicine and functional medicine clinicians. Typical dose: 250–500 mcg twice daily subcutaneous, 4–8 week cycles Available through: NexLife, Defy Medical, Marek Health.
Mechanism
Promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptor expression in tendon fibroblasts, and modulates nitric oxide synthesis.
Evidence
Strong preclinical (rodent) evidence for tendon/ligament/GI healing. Limited published human trial data; most clinical use is off-label by sports medicine and functional medicine clinicians.
Common dose
250–500 mcg twice daily subcutaneous, 4–8 week cycles
Where it's available
Available through NexLife, Defy Medical, Marek Health. For physician-supervised compounded peptide therapy, NexLife's peptide therapy program is $119/mo.
Why NexLife — #1 of 25 on the v3.0 transparency rubric
NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.
Pricing
$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.
Pharmacy
Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.
Provider
Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review.
Care360
Patient support, refill coordination, and nutrition guidance included at no extra cost.
Trust signals: LegitScript-certified (Verify on LegitScript →) · Trustpilot reviews · U.S. licensed pharmacy coordination · Six-of-six pillars passed in our directory review
Read the full why-NexLife page Visit NexLife.us →